Understanding Morr 12.5% Intas Pharmaceuticals
Morr 12.5% is a topical minoxidil solution manufactured by Intas Pharmaceuticals, formulated for laboratory investigations into cardiovascular physiology and vasodilation mechanisms. This pharmaceutical-grade preparation enables researchers to examine the effects of high-concentration minoxidil on vascular smooth muscle tissue and peripheral blood flow dynamics. Scientists studying hypertension models and vascular reactivity commonly utilise this compound to investigate potassium channel activation pathways and their role in vasodilation. Our research community at Stroid UK Shop utilises this solution alongside other cardiovascular research compounds for comprehensive vascular studies.
Laboratory Applications
Research teams investigate Morr 12.5% in multiple experimental contexts including vascular smooth muscle cell culture studies, ex-vivo tissue bath experiments, and cardiovascular pharmacology protocols. The compound’s mechanism involves opening ATP-sensitive potassium channels in vascular smooth muscle, leading to membrane hyperpolarisation and subsequent vasodilation. Laboratory protocols commonly examine dose-response relationships, temporal dynamics of vascular effects, and interactions with other cardiovascular modulators. Researchers studying hair follicle biology also utilise this preparation to investigate dermal papilla cell proliferation and angiogenesis pathways. Studies frequently compare minoxidil’s effects against other vasodilatory compounds available in our selective androgen receptor modulator and peptide research collections to understand differential mechanisms of tissue-specific effects.
Product Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Minoxidil 12.5% |
| Manufacturer | Intas Pharmaceuticals |
| Form | Topical Solution |
| CAS Number | 38304-91-5 |
| Molecular Formula | C₉H₁₅N₅O |
| Molecular Weight | 209.25 g/mol |
| Storage | Room temperature, dry place |
Research Compliance
This product is supplied exclusively for in-vitro laboratory research purposes. Morr 12.5% is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate safety protocols and institutional oversight when handling this compound. All experimental procedures should comply with relevant laboratory safety guidelines and institutional review board requirements for cardiovascular research studies.
